MuniMetrics MVP v6.6.5

Internal municipal credit analysis workbench

Senior Credit Analyst AI Summary

Issuer: State of New York | Bond: Series 2025A Tax-Exempt Bonds, Series 2025B Taxable Bonds, and Series 2025C Tax-Exempt Refunding Bonds

Back to Review
# Senior Credit Analyst Summary ## 1. Executive Credit View Preliminary only. The provided excerpt is a State of New York Comptroller monthly cash-basis report, not an official statement for the Series 2025A/B/C bonds. It supports a high-level liquidity and cash-flow read for the State, but it does not provide bond-specific security, maturity, call, rating, debt service, or offering details. Based only on the excerpt, the State shows very large governmental fund balances and broad tax/federal receipt flows, which are positive. However, the period also shows a sizable year-to-date decline in total governmental fund balance after other financing uses, heavy dependence on federal receipts, and rapid Medicaid/public health spending growth. The document supports a **preliminary Watch implication**, not a final Buy or Pass, pending bond documents and full credit materials. ## 2. Issuer and Bond Facts Extracted - **Issuer:** State of New York. Identified in report heading. Page 2. - **Bond name:** Series 2025A Tax-Exempt Bonds, Series 2025B Taxable Bonds, and Series 2025C Tax-Exempt Refunding Bonds — identified in analyst-entered context, but **not identified in provided excerpt**. - **Par amount:** Not identified in provided excerpt. - **Bond type:** Analyst-entered context states General Obligation; **not confirmed in provided excerpt**. - **Security pledge:** Not identified in provided excerpt. - **Purpose:** Not identified in provided excerpt. - **Maturity range:** Not identified in provided excerpt. - **Rating:** Not identified in provided excerpt. - **Underwriter:** Not identified in provided excerpt. - **Bond counsel:** Not identified in provided excerpt. - **Municipal advisor:** Not identified in provided excerpt. - **Registrar / paying agent:** Not identified in provided excerpt. - **Tax status:** Analyst-entered context identifies Series 2025A and 2025C as tax-exempt and Series 2025B as taxable; **not confirmed in provided excerpt**. ## 3. Security and Bond Structure Analysis The excerpt does **not** provide the legal security pledge for the Series 2025 bonds, the constitutional or statutory GO pledge language, debt service schedule, flow of funds, remedies, call features, redemption provisions, refunding escrow details, or additional issuance limitations. Relevant State cash-flow observations from the excerpt: - Governmental funds ended the eight-month period with total fund balances of **$67.994 billion**, up **$1.221 billion / 1.8%** from the prior year comparison. Page 3. - General Fund ending balance was **$47.881 billion**. Page 3. - Debt Service Fund ending balance was **$165.6 million**. Page 3. - Debt service disbursements, including payments on other financing arrangements, were **$295.0 million** for the eight months ended November 30, 2025, down from **$348.3 million** in the prior year period. Page 3. - No bond or note proceeds were reported in governmental funds for the period shown. Page 3. These are useful cash-basis indicators, but they do not substitute for bond security analysis. ## 4. Credit Strengths - **Large reported cash balances:** Total governmental fund balances were **$67.994 billion** and General Fund balance was **$47.881 billion** at November 30, 2025. Page 3. - **Broad revenue base evident in cash receipts:** The State reports substantial personal income tax, consumption/use tax, business tax, other tax, miscellaneous, and federal receipts. Total governmental receipts were **$160.794 billion** for the eight months ended November 30, 2025. Page 3. - **Year-over-year receipt growth:** Total governmental receipts increased by **$9.246 billion / 6.1%** versus the prior-year period. Page 3. - **Personal income tax growth:** Personal income tax receipts were **$38.231 billion** for the eight-month period, up **$2.902 billion / 8.2%** year over year. Page 3. - **Consumption/use tax growth:** Consumption/use tax receipts were **$15.670 billion**, up **$865.5 million / 5.8%** year over year. Page 3. - **Positive pre-transfer operating position on total governmental funds:** Receipts exceeded disbursements by **$427.6 million** for total governmental funds before other financing sources/uses. Page 3. ## 5. Credit Risks and Watch Items - **Cash-basis report only:** The excerpt is not an audited financial statement, official statement, rating report, or continuing disclosure filing. It does not provide GAAP results, reserves policy, debt affordability metrics, pension/OPEB liabilities, or full economic context. - **Total governmental funds declined after transfers:** After other financing sources and uses, total governmental funds had an eight-month deficiency of **$5.703 billion**, compared with a positive **$860.4 million** in the prior-year period. Page 3. - **General Fund drawdown:** General Fund ending balance declined from beginning balance of **$56.916 billion** to **$47.881 billion**, an eight-month decrease of **$9.034 billion** after transfers. Page 3. - **Capital Projects deficit:** Capital Projects Funds showed an ending deficit of **$2.412 billion**, worsening from a beginning deficit of **$1.456 billion**. Page 3. - **Heavy federal-receipt component:** Federal receipts totaled **$67.879 billion** for the eight-month period, representing a large share of total governmental receipts. Page 3. The excerpt does not distinguish recurring federal reimbursements from temporary or restricted federal aid. - **Medicaid spending pressure:** Medicaid local assistance disbursements were **$67.051 billion** for the eight-month period, up **$7.222 billion / 12.1%** year over year. Page 3. - **Other public health spending pressure:** Other public health disbursements were **$15.505 billion**, up **$1.829 billion / 13.4%** year over year. Page 3. - **Departmental and fixed-cost growth:** Personal service disbursements increased **9.0%**, non-personal service increased **6.1%**, and general state charges increased **10.1%** year over year. Page 3. - **Bond-specific risk not assessable:** Security pledge, debt service coverage, maturity amortization, refunding savings, call structure, ratings, and legal protections are not identified in the excerpt. ## 6. Temporary / Artificial Funding Exposure ### Item 1: COVID-related unemployment insurance reimbursement payment - **Source / program:** Department of Labor Unemployment Insurance / SUNY Hospital IFR Fund Clearing Account; payment to the federal government as reimbursement for disbursements incurred during the COVID pandemic. - **Amount:** **$6.0 billion**. - **Fiscal year or period:** June 2025. - **Apparent use of funds:** Payment to the federal government as reimbursement for COVID-pandemic-related unemployment insurance disbursements. - **Classification:** Reimbursement Funding. - **Risk level:** Medium. - **Why it matters to recurring credit strength:** This appears to be a reimbursement/settlement-type cash event related to pandemic-period disbursements rather than recurring operating revenue. It may distort cash-flow comparability and should be separated from recurring budget operations. The excerpt does not indicate that the item supported ongoing payroll, recurring operations, reserve growth, or debt service. - **Page citation:** Page 5. ### Item 2: Federal share of Medicaid and federal reimbursements related to Capital Projects / Special Revenue transfers - **Source / program:** Federal share of Medicaid and federal government reimbursements; referenced with Public Authorities Fund and Department of Health Income Fund reimbursements. - **Amount:** **$1.1224 billion**. - **Fiscal year or period:** Not clearly identified in provided excerpt. - **Apparent use of funds:** Reimbursements connected to certain Capital Projects fund disbursements financed by operating transfers from other Special Revenue Funds. - **Classification:** Reimbursement Funding / Restricted Funding. - **Risk level:** Low to Medium. - **Why it matters to recurring credit strength:** Federal Medicaid reimbursements can be a recurring component of state cash flows, but the excerpt does not provide enough detail to separate normal federal matching reimbursements from one-time timing items. The apparent reimbursement character reduces concern relative to deficit backfill, but the size of federal flows remains a watch item. - **Page citation:** Page 5. ### Item 3: Federal grant-related account reference - **Source / program:** Federal Grants Indirect Cost Recovery Account and related account listing. - **Amount:** Specific federal grant amount not clearly identified in the excerpt. The scanned excerpt includes account-level figures but does not clearly tie them to a discrete grant inflow or use. - **Fiscal year or period:** Not clearly identified in provided excerpt. - **Apparent use of funds:** Unclear from excerpt. - **Classification:** Unclear. - **Risk level:** Medium. - **Why it matters to recurring credit strength:** Federal grant funds may be restricted, reimbursement-based, pass-through, or temporary. The excerpt does not identify whether the funds supported recurring operations, capital projects, indirect cost recovery, or pass-through activity. Analyst should not treat this as recurring unrestricted support without additional documentation. - **Page citation:** Page 54. ### Item 4: Broad federal receipts - **Source / program:** Federal Receipts across governmental funds. - **Amount:** **$67.879 billion** for the eight months ended November 30, 2025; up **$2.975 billion / 4.6%** year over year. - **Fiscal year or period:** Eight months ended November 30, 2025. - **Apparent use of funds:** Not fully detailed; shown primarily in Special Revenue funds, with some Capital Projects and Debt Service federal receipts. Page 3. - **Classification:** Unclear / Restricted Funding. - **Risk level:** Medium. - **Why it matters to recurring credit strength:** The State’s cash receipts include a very large federal component. The excerpt does not identify whether these are recurring formula reimbursements, restricted program funds, pass-through local assistance, capital reimbursements, or temporary pandemic/rescue-plan funds. Because Medicaid and other local assistance spending are large, the analyst should isolate recurring federal reimbursement streams from any temporary aid before assessing normalized operating strength. - **Page citation:** Page 3. ## 7. Reported vs. Recurring Strength Implications The excerpt suggests reported cash strength may differ from recurring operating strength. Reported liquidity is very strong on its face, with **$67.994 billion** of total governmental fund balances and **$47.881 billion** in the General Fund. Page 3. However, the eight-month period also shows a **$5.703 billion** total governmental funds decline after other financing sources/uses and a **$9.034 billion** General Fund decline. Page 3. Federal receipts are significant at **$67.879 billion**, and some identified items involve COVID-related reimbursement and federal reimbursements. Pages 3 and 5. The excerpt does not show whether federal receipts are recurring, restricted, reimbursement-based, or temporary. Therefore, the State’s reported cash position should be normalized for one-time pandemic-related transactions, federal reimbursements, pass-through grants, and timing-related transfers before drawing conclusions about recurring credit strength. ## 8. Missing Information / Analyst Follow-Up Before a final investment thesis, obtain and review: - Official Statement or preliminary official statement for Series 2025A/B/C. - Full legal security pledge for the GO bonds. - Par amount by series. - Maturity schedule and amortization